Risk factors of proteinuria in renal cell carcinoma patients treated with VEGF inhibitors: a secondary analysis of pooled clinical trial data

BACKGROUND: Proteinuria is a common adverse effect of vascular endothelial growth factor targeted agents, particularly in metastatic renal cell carcinoma (mRCC). However, risk factors for proteinuria are poorly defined. METHODS: Data on 1392 mRCC patients using pazopanib or sunitinib were pooled fro...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Br J Cancer
Autors principals: Sorich, Michael J, Rowland, Andrew, Kichenadasse, Ganessan, Woodman, Richard J, Mangoni, Arduino A
Format: Artigo
Idioma:Inglês
Publicat: Nature Publishing Group 2016
Matèries:
Clinical Study
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC4984472/
https://ncbi.nlm.nih.gov/pubmed/27228299
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/bjc.2016.147
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars